Complete ICD-10-CM coding and documentation guide for ESBL Infections. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to ESBL Infections
Resistance to antimicrobial drugs
This range includes codes for resistance to antimicrobial drugs, specifically Z16.12 for ESBL resistance.
Urinary tract infection, site not specified
Used for coding urinary tract infections, which can be caused by ESBL-producing organisms.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
Z16.12 | Resistance to extended-spectrum beta-lactamase (ESBL) | Use when ESBL resistance is confirmed by lab tests and documented in the patient's record. |
|
A41.5 | Sepsis due to Gram-negative organism | Use when sepsis is confirmed and linked to an ESBL-producing organism. |
|
N39.0 | Urinary tract infection, site not specified | Use for UTIs confirmed to be caused by ESBL-producing organisms. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about ESBL Infections
Use when sepsis is confirmed and linked to an ESBL-producing organism.
Ensure sepsis is documented with clinical indicators and lab confirmation.
Use for UTIs confirmed to be caused by ESBL-producing organisms.
Ensure UTI is documented with lab confirmation of ESBL organism.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Avoid these common documentation and coding issues when documenting ESBL Infections to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code Z16.12.
Clinical: Leads to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential claim rejections.
Always document the specific organism., Review lab reports before coding.
Reimbursement: Incorrect sequencing can lead to claim denials., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data on antimicrobial resistance.
Always sequence Z16.12 after the primary infection code.
Incorrect coding of antimicrobial resistance can lead to audits.
Ensure all resistance is lab-confirmed and documented.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for ESBL Infections, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for ESBL Infections. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for ESBL Infections? Ask your questions below.